Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
CPSE:NOVO B
Novo Nordisk A/S
|
910.00 | -1,79% | 18,59% | 4.053.901,21 | 1,03% | 18,5% |
|
NYSE:JNJ
Johnson & Johnson
|
151.38 | 0% | 0% | 364.323,09 | 3,28% | 2,71% |
|
LSE:AZN
AstraZeneca PLC
|
122.46 | 17,57% | 40,04% | 189.841,78 | 2% | 15,98% |
|
SWX:NOVN
Novartis
|
93.49 | 8,01% | 21,37% | 190.757,59 | 3,55% | 4,67% |
|
NYSE:ABT
Abbott Laboratories
|
104.01 | 2,51% | 15,26% | 180.939,31 | 2,1% | 9,04% |
|
NasdaqGS:AMGN
Amgen
|
311.41 | -11,96% | -3,14% | 167.051,13 | 2,92% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.38 | 9,41% | 39,92% | 160.817,91 | 5,91% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
91.69 | 16,05% | 34,5% | 114.488,32 | 4,06% | 8,19% |
|
LSE:GSK
GSK
|
18.10 | 5,36% | 20,88% | 73.812,48 | 3,2% | 0,79% |
|
ASX:CSL
CSL
|
279.58 | 22,78% | 43,75% | 135.107,8 | 1,28% | 7,18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.65 | 21,02% | 30,29% | 84.281,97 | 4,56% | 0,15% |
|
XTRA:MRK
Merck KGaA
|
158.30 | 8,74% | 24,31% | 68.825,34 | 1,42% | 10,29% |
|
NasdaqGS:MRNA
Moderna
|
128.32 | -.111,1% | -.107,66% | 49.177,32 | 0% | 0% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
17.09 | -48,73% | -45,42% | 19.356,83 | 0% | -2,6% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
147.89 | 0% | 0% | 18.706,87 | 0% | 0% |
|
NYSE:BAX
Baxter International Inc
|
35.24 | 82,83% | 110,41% | 17.957,61 | 3,27% | -3,14% |
|
NYSE:LH
Laboratory Corp of America Holdings
|
211.20 | -11,43% | -1,94% | 17.802,81 | 1,37% | 4,24% |
|
TSE:4503
Astellas Pharma
|
1521.00 | 0% | 0% | 2.727.132,35 | 4,9% | 0% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
79.65 | 142,2% | 221,62% | 15.385,96 | 0% | 32,46% |
|
NYSE:DGX
Quest Diagnostics
|
139.16 | -6,93% | 2,11% | 15.377,3 | 2,13% | 6,66% |
